Cargando…
Treatment outcomes of IMEP as a front-line chemotherapy for patients with peripheral T-cell lymphomas
BACKGROUND: This study aimed to assess the treatment outcomes of ifosphamide, mesna, etoposide, and prednisolone (IMEP) combination regimen as a front-line chemotherapy in patients with peripheral T-cell lymphomas (PTCLs). METHODS: Clinical data of 38 newly diagnosed PTCLs patients who underwent IME...
Autores principales: | Lee, Ji Young, Lee, Sang Min, Choi, Moon Young, Kim, Ki Hyang, Joo, Young Don, Im, Sung Nam, Lee, Won Sik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5054251/ https://www.ncbi.nlm.nih.gov/pubmed/27722130 http://dx.doi.org/10.5045/br.2016.51.3.187 |
Ejemplares similares
-
Determination of total cadmium, lead, arsenic, mercury and inorganic arsenic in mushrooms: outcome of IMEP-116 and IMEP-39
por: Cordeiro, F., et al.
Publicado: (2015) -
The role of front-line anthracycline-containing chemotherapy regimens in peripheral T-cell lymphomas
por: Briski, R, et al.
Publicado: (2014) -
Controversies in the Front-Line Treatment of Systemic Peripheral T Cell Lymphomas
por: Sorigue, Marc, et al.
Publicado: (2022) -
A Systematic Review and Meta-Analysis of Front-line Anthracycline-Based Chemotherapy Regimens for Peripheral T-Cell Lymphoma
por: AbouYabis, Abeer N., et al.
Publicado: (2011) -
Gemcitabine, Etoposide, Cisplatin, and Dexamethasone in Patients With Refractory or Relapsed Non-Hodgkin's Lymphoma
por: Kim, Ki-Hyang, et al.
Publicado: (2009)